Proteomics International Laboratories Ltd (ASX:PIQ) Study Validates Biomarkers for Endometriosis Blood Test

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics is pleased to announce a milestone for its novel blood test for endometriosis, PromarkerEndo, with the clinical validation of the biomarker panel in an independent patient group.

Related Keywords

Perth ,Western Australia ,Australia ,Subiaco ,Richard Lipscombe ,Proteomics International Laboratories Ltd ,God Subiaco Hospital Gynaecological Cancer Research Group ,Australasian Proteomics Society ,Proteomics International ,Proteomics International Laboratories ,Validates Biomarkers ,Endometriosis Blood ,International Laboratories Ltd ,Annual Lorne Proteomics Symposium ,Managing Director Dr Richard Lipscombe ,International Laboratories ,Biotech ,Health Pharm Generalproteomics International Laboratories Ltd ,Asx Piq ,